However, it is necessary to analyse whether pre-treatment of cervical tumour cells with HO-1 inhibitors improves the cytotoxicity of NK cells or if the better production of IFN-γ and TNF-α impacts the activation of other cells of the immune system [80,81]. This evidence concerns the gene HMOX1 and uterine cervix neoplasm.